BlueRock Therapeutics' Incubator/Accelerator Round

BlueRock Therapeutics raised a round of funding on August 21, 2017. Investors include JLabs.

BlueRock Therapeutics is a next-generation regenerative medicine company that plans to develop best-in-class induced pluripotent stem cell (iPSC) therapies to cure a range of diseases using an industr…

Articles about BlueRock Therapeutics' Incubator/Accelerator Round: